Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis
- PMID: 25130937
- PMCID: PMC4326601
- DOI: 10.1016/j.cgh.2014.07.060
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis
Abstract
Background & aims: Bacterial infections, particularly repeated infections, are significant causes of morbidity and mortality among patients with cirrhosis. We investigated and characterized risk factors for repeat infections in these patients.
Methods: In a prospective study, we collected data from 188 patients hospitalized with cirrhosis and infections and enrolled in the North American Consortium for the Study of End-Stage Liver Disease (12 centers). Patients were followed up for 6 months after hospital discharge and data were analyzed on type of infections and factors associated with subsequent infections.
Results: Six months after hospital discharge, 14% of subjects had received liver transplants, 27% died, and 59% were alive without liver transplantation. After discharge, 45% had subsequent infections, but only 26% of the subsequent infections occurred at the same site. Compared with patients not re-infected, patients with repeat infections were older and a higher proportion used proton pump inhibitors (PPIs) (P = .006), rifaximin (P < .001), or prophylactic therapy for spontaneous bacterial peritonitis (SBP) (P < .001). Logistic regression showed that SBP prophylaxis (odds ratio [OR], 3.44; 95% confidence interval [CI], 1.56-7.63), PPI use (OR, 2.94; 95% CI, 1.39-6.20), SBP at hospital admission (OR, 0.37; 95% CI, 0.15-0.91), and age (OR, 1.06; 95% CI, 1.02-1.11) were independent predictors of subsequent infections.
Conclusions: Patients hospitalized with cirrhosis and infections are at high risk for subsequent infections, mostly at different sites, within 6 months of index infection resolution. Those at highest risk include previously infected older patients receiving PPIs and/or SBP prophylaxis, although these associations do not prove that these factors cause the infections. New strategies are needed to prevent infections in patients with cirrhosis.
Keywords: Antibiotic; Complication; Decompensation; NACSELD.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Comment in
-
Long-term antibiotics and PPI's induce bacterial translocation in patients with cirrhosis: antibiotics are not always ANTI-biotics.Turk J Gastroenterol. 2014 Aug;25(4):472. doi: 10.5152/tjg.2014.0040. Turk J Gastroenterol. 2014. PMID: 25254548 No abstract available.
-
Preventing future infections in cirrhosis: a battle cry for stewardship.Clin Gastroenterol Hepatol. 2015 Apr;13(4):760-2. doi: 10.1016/j.cgh.2014.10.025. Epub 2014 Nov 5. Clin Gastroenterol Hepatol. 2015. PMID: 25460013 No abstract available.
-
Subsequent Bacterial Infections in Patients With Cirrhosis and the Role of Proton-Pump Inhibitors.Clin Gastroenterol Hepatol. 2015 Nov;13(11):2026-7. doi: 10.1016/j.cgh.2014.12.015. Epub 2014 Dec 22. Clin Gastroenterol Hepatol. 2015. PMID: 25541194 No abstract available.
-
Reply: To PMID 25130937.Clin Gastroenterol Hepatol. 2015 Nov;13(11):2028. doi: 10.1016/j.cgh.2015.05.006. Epub 2015 May 9. Clin Gastroenterol Hepatol. 2015. PMID: 25967751 No abstract available.
Similar articles
-
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.PLoS One. 2014 Nov 4;9(11):e110503. doi: 10.1371/journal.pone.0110503. eCollection 2014. PLoS One. 2014. PMID: 25369194 Free PMC article.
-
Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.J Hepatol. 2015 May;62(5):1056-60. doi: 10.1016/j.jhep.2014.11.036. Epub 2014 Dec 4. J Hepatol. 2015. PMID: 25481567
-
Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.Am J Gastroenterol. 2009 May;104(5):1130-4. doi: 10.1038/ajg.2009.80. Epub 2009 Mar 31. Am J Gastroenterol. 2009. PMID: 19337238
-
Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.Curr Med Sci. 2022 Aug;42(4):673-680. doi: 10.1007/s11596-022-2607-3. Epub 2022 Jul 23. Curr Med Sci. 2022. PMID: 35870102 Review.
-
Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.South Med J. 2018 Nov;111(11):660-665. doi: 10.14423/SMJ.0000000000000887. South Med J. 2018. PMID: 30392000 Review.
Cited by
-
Management of acute variceal bleeding.Clin Liver Dis (Hoboken). 2024 Jun 28;23(1):e0176. doi: 10.1097/CLD.0000000000000176. eCollection 2024 Jan-Jun. Clin Liver Dis (Hoboken). 2024. PMID: 38952694 Free PMC article. Review.
-
Chronic Liver Disease in the Older Patient-Evaluation and Management.Curr Gastroenterol Rep. 2023 Dec;25(12):390-400. doi: 10.1007/s11894-023-00908-2. Epub 2023 Nov 22. Curr Gastroenterol Rep. 2023. PMID: 37991713 Review.
-
Austrian consensus on the diagnosis and management of portal hypertension in advanced chronic liver disease (Billroth IV).Wien Klin Wochenschr. 2023 Sep;135(Suppl 3):493-523. doi: 10.1007/s00508-023-02229-w. Epub 2023 Jun 26. Wien Klin Wochenschr. 2023. PMID: 37358642 Free PMC article.
-
Cirrhotic patients on proton pump inhibitors are at a twofold risk of spontaneous bacterial peritonitis independently of gastrointestinal bleeding: a population-based retrospective study.Ann Gastroenterol. 2023 May-Jun;36(3):327-332. doi: 10.20524/aog.2023.0794. Epub 2023 Apr 8. Ann Gastroenterol. 2023. PMID: 37144010 Free PMC article.
-
Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial.EClinicalMedicine. 2023 Apr 4;58:101924. doi: 10.1016/j.eclinm.2023.101924. eCollection 2023 Apr. EClinicalMedicine. 2023. PMID: 37090442 Free PMC article.
References
-
- Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42. - PubMed
-
- Wong F, O'Leary JG, Reddy KR, Patton H, Kamath PS, Fallon MB, Garcia-Tsao G, Subramanian RM, Malik R, Maliakkal B, Thacker LR, Bajaj JS. New Consensus Definition of Acute Kidney Injury Accurately Predicts 30-day Mortality in Patients with Cirrhosis with Infection. Gastroenterology. 2013 - PMC - PubMed
-
- Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:727–38. - PubMed
-
- Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102:1510–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
